Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Scalp Block with Bupivacaine

Preclinical

CCairo University

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Regional AnesthesiaRecruiting

Regional AnesthesiaPreclinical

Recruiting

Timeline

Expected Milestones

Q3 2026

PreclinicalRecruiting

Regional Anesthesia

NCT07698665

Clinical

Trials by Indication[1]

Regional Anesthesia1 trial

Efficacy of Ketamine Versus Dexmedetomidine as an Adjuvant to Bupivacaine in Scalp Block in Adults Undergoing Supratentorial Brain Tumor Excision Surgeries for Hemodynamics and Pain Control, Double-blinded Randomized Study

Recruiting·CCairo University·Preclinical·NCT07698665·90 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Scalp Block with Bupivacaine. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Scalp Block with Bupivacaine. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Cairo University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: CCairo University

Related News